Souglakos, John

Duration of adjuvant chemotherapy for stage III colon cancer

Grothey, A., Sobrero, A. F., Shields, A. F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., et al. (2018) · New England Journal of Medicine

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 1,092

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Yonesaka, K., Zejnullahu, K., Okamoto, I., Satoh, T., Cappuzzo, F., Souglakos, J., Ercan, D., Rogers, A., Roncalli, M., Takeda, M., et al. (2011) · Science Translational Medicine

HER2/EGFR in Cancer ResearchColorectal Cancer Treatments and Studies

Cited by 663

Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study

Karampeazis, A., Voutsina, A., Souglakos, J., Kentepozidis, N., Giassas, S., Christofillakis, C., Kotsakis, A., Papakotoulas, P., Rapti, A., Agelidou, M., et al. (2013) · Cancer

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 113

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients

Koulouridi, A., Karagianni, M., Messaritakis, I., Sfakianaki, M., Voutsina, A., Trypaki, M., Bachlitzanaki, M., Koustas, E., Karamouzis, M. V., Ntavatzikos, A., et al. (2022) · Cancers

Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer

Cited by 63

Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer

Fotsitzoudis, C., Koulouridi, A., Messaritakis, I., Konstantinidis, T., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2022) · Cancers

Cancer Cells and MetastasisTGF-β signaling in diseases

Cited by 46

Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy

Nikolouzakis, T. K., Chrysos, E., Docea, A. O., Fragkiadaki, P., Souglakos, J., Tsiaoussis, J., & Tsatsakis, A. (2024) · Cancers

Colorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers

Cited by 37

Novel Prognostic Biomarkers in Metastatic and Locally Advanced Colorectal Cancer: Micronuclei Frequency and Telomerase Activity in Peripheral Blood Lymphocytes

Nikolouzakis, T. K., Vakonaki, E., Stivaktakis, P. D., Alegakis, A., Berdiaki, A., Razos, N., Souglakos, J., Tsatsakis, A., & Tsiaoussis, J. (2021) · Frontiers in Oncology

Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer

Cited by 17

P02-06: Effect of systemic treatment on telomere length of patients with metastatic colorectal cancer

Nikolouzakis, T. K., Vakonaki, E., Alegakis, A., Rakitskii, V., Svistunov, A., Chrysos, E., Souglakos, J., Tsatsakis, A. M., & Tsiaoussis, J. (2023) · Toxicology Letters

Telomeres, Telomerase, and SenescenceColorectal Cancer Treatments and Studies

Cited by 1